Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Vox Sang ; 117(2): 251-258, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1685461

ABSTRACT

BACKGROUND AND OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the vulnerability of platelet supply and the uncertain impact of the resumption of elective surgery on utilization. We report the impact of COVID-19 on platelet supply and utilization across a large, integrated healthcare system in the Canadian province of British Columbia (BC). MATERIALS AND METHODS: Historical platelet use in BC by indication was compiled for fiscal year 2010/2011-2019/2020. Platelet collections, initial daily inventory and disposition data were assessed pre-COVID-19 (1 April 2018-15 March 2020) and for two COVID-19 time periods in BC: a shutdown phase with elective surgeries halted (16 March-17 May, 2020) and a renewal phase when elective surgeries resumed (18 May-27 September 2020); comparisons were made provincially and for individual health authorities. RESULTS: Historically, elective surgeries accounted for 10% of platelets transfused in BC. Initial daily supplier inventory increased from baseline during both COVID-19 periods (93/90 units vs. 75 units pre-COVID-19). During the shutdown phase, platelet utilization decreased 10.4% (41 units/week; p < 0.0001), and remained significantly decreased during the ensuing renewal period. Decreased platelet utilization was attributed to fewer transfusions during the shutdown phase followed by a decreased discard/expiry rate during the renewal phase compared to pre-COVID-19 (15.2% vs. 18.9% pre-COVID-19; p < 0.0001). Differences in COVID-19 platelet utilization patterns were noted between health authorities. CONCLUSION: Decreased platelet utilization was observed in BC compared to pre-COVID-19, likely due to a transient reduction in elective surgery as well as practice and policy changes triggered by pandemic concerns.


Subject(s)
COVID-19 , Blood Platelets , British Columbia , Elective Surgical Procedures , Humans , SARS-CoV-2
2.
Photonics ; 8(11):468, 2021.
Article in English | ProQuest Central | ID: covidwho-1534229

ABSTRACT

A signal space diversity (SSD) scheme was proposed to be incorporated with spatial modulation (SM) in an intensity-modulation/direct-detection-based multiple-input-single-output (MISO) indoor optical wireless communication (OWC) system to improve bit-error-rate (BER) performance and system throughput. SSD was realized via signal constellation rotation and diversity interleaving using different channel gains to improve the BER. With SM incorporated, the MISO-OWC system throughput increased. Theoretical BER expressions of the SSD scheme were established for the first time by investigating the distance of neighboring constellation symbols upon maximum-likelihood detection. Such BER expressions were further verified by numerical results. The results showed that, except for the slightly-lower-accuracy performance brought by comparable distances of neighboring constellation symbols in cases of low signal-to-noise ratios, these BER expressions were accurate in most scenarios. Moreover, theoretical investigations of channel gain distributions were performed at different signal constellation rotation angles to show the capability of the SSD scheme to improve the BER. The results showed that a significantly improved BER by two orders of magnitude could be achieved using a reasonably high channel-gain ratio and a larger constellation rotation angle. The SSD-SM scheme provides a promising option to achieve transmitter diversity with an enhanced throughput in high-speed indoor OWC systems.

3.
Eur J Ophthalmol ; 31(5): 2268-2274, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-733071

ABSTRACT

BACKGROUND: During the current coronavirus (COVID-19) pandemic, some ophthalmologists across the United Kingdom (UK) have been redeployed to areas of need across the National Health Service (NHS). This survey was performed to assess aspects of this process including training & education, tasks expected, availability of personal protection equipment (PPE) used and the overall anxiety of ophthalmologists around their redeployment. METHOD: Online anonymous survey around the existing guidance on safe redeployment of secondary care NHS staff and PPE use by NHS England and Public Health England respectively. The survey was open to all ophthalmologists across the UK irrespective of their redeployment status. FINDINGS: 145 surveys were completed and returned during a 2-week period between 17th April 2020 and 1st May 2020, when 52% of ophthalmologists were redeployed. The majority of this group consisted of ophthalmologists in training (79%). 81% of those redeployed were assigned to areas of the hospital where patients with confirmed Coronavirus disease were being treated as inpatients. There was a statistically significant improvement in anxiety level following redeployment which was mainly attributed to the support received by staff within the redeployed area. 71% of the redeployed group were found to have sufficient PPE was provided for the area they worked in. INTERPRETATION: This is the first national survey performed on redeployment of ophthalmologists in the UK. The study showed that ophthalmologists across all grades were able to contribute in most aspects of patient care. Anxiety of redeployment was reduced by prior training and good support in the redeployment area.


Subject(s)
COVID-19 , Ophthalmologists , Humans , Pandemics , SARS-CoV-2 , State Medicine , United Kingdom/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL